Albumin augmentation improves condition of guinea pig hearts after 4 hr of cold ischemia

Transplantation

Volumn 87, Issue 7, 2009, Pages 956-965

  Jacob, Matthias ^a,c   Paul, Oliver ^a,b   Mehringer, Laurenz ^a,b   Chappell, Daniel ^a   Rehm, Markus ^a   Welsch, Ulrich ^a   Kaczmarek, Ingo ^a   Conzen, Peter ^a   Becker, Bernhard F ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c NONE   (Germany)

Author keywords

Endothelial glycocalyx; Endothelial surface layer; Guinea pig heart; Heart preservation; Human albumin

Indexed keywords

HTK SOLUTION; HUMAN ALBUMIN; BRETSCHNEIDER CARDIOPLEGIC SOLUTION; GLUCOSE; MANNITOL; POTASSIUM CHLORIDE; PRESERVATION SOLUTION; PROCAINE; SERUM ALBUMIN;

ANIMAL TISSUE; ARTICLE; CELL ADHESION; COLD ISCHEMIA; CONTROLLED STUDY; EDEMA; ENDOTHELIUM; GLYCOCALYX; GUINEA PIG; HEART OUTPUT; HEART PERFORMANCE; HEART PRESERVATION; HEART TRANSPLANTATION; MALE; NEUTROPHIL; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; ANIMAL; ANIMAL MODEL; CORONARY BLOOD VESSEL; DRUG EFFECT; HEART; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOLOGY; METHODOLOGY; ORGAN PRESERVATION; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT FAILURE; VASCULAR ENDOTHELIUM;

ANIMALS; CARDIAC OUTPUT; CELL ADHESION; CORONARY VESSELS; EDEMA; ENDOTHELIUM, VASCULAR; GLUCOSE; GUINEA PIGS; HEART; HEART TRANSPLANTATION; HUMANS; MANNITOL; MODELS, ANIMAL; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEUTROPHILS; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; POTASSIUM CHLORIDE; PROCAINE; SERUM ALBUMIN; TREATMENT FAILURE;

EID: 65549124024     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31819c83b5     Document Type: Article

References (47)

1. Kass M, Haddad H. Cardiac allograft vasculopathy: Pathology, prevention and treatment. Curr Opin Cardiol 2006; 21: 132.
2. Southard JH, Belzer FO. Organ preservation. Annu Rev Med 1995; 46: 235.
3. Maathuis MH, Leuvenink HG, Ploeg RJ. Perspectives in organ preservation. Transplantation 2007; 83: 1289.
4. Buckberg GD. Myocardial temperature management during aortic clamping for cardiac surgery. Protection, preoccupation, and perspective. J Thorac Cardiovasc Surg 1991; 102: 895.
5. Jahania MS, Sanchez JA, Narayan P, Lasley RD, Mentzer RM Jr. Heart preservation for transplantation: Principles and strategies. Ann Thorac Surg 1999; 68: 1983.
6. Keck BM, White R, Breen TJ, et al. Thoracic organ transplants in the United States: A report from the UNOS/ISHLT Scientific Registry for Organ Transplants. United Network for Organ Sharing. International Society for Heart and Lung Transplantation. Clin Transpl 1994; 37.
7. Musameh MD, Green CJ, Mann BE, et al. Improved myocardial function after cold storage with preservation solution supplemented with a carbon monoxide-releasing molecule (CORM-3). J Heart Lung Transplant 2007; 26: 1192.
8. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 2007; 26: 769.
9. Miniati DN, Grunenfelder J, Hoyt EG, et al. Oxidative stress of cardiac transplantation is associated with decreased BCL-2 expression and increased NFKB activity. J Heart Lung Transplant 2001; 20: 158.
10. Pries AR, Secomb TW, Gaehtgens P. The endothelial surface layer. Pflugers Arch 2000; 440: 653.
11. Adamson RH, Lenz JF, Zhang X, et al. Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J Physiol 2004; 557: 889.
12. Jacob M, Bruegger D, Rehm M, et al. The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. Cardiovasc Res 2007; 73: 575.
13. Chappell D, Jacob M, Hofmann-Kiefer K, et al. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 2007; 107: 776.
14. Jacob M, Bruegger D, Rehm M, et al. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 2006; 104: 1223.
15. Rehm M, Zahler S, Lotsch M, et al. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 2004; 100: 1211.
16. Henry CB, Duling BR. TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol 2000; 279: H2815.
17. Pries AR, Kuebler WM. Normal endothelium. Handb Exp Pharmacol 2006; 1: 1.
18. Davis SF, Yeung AC, Meredith IT, et al. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant. Circulation 1996; 93: 457.
19. Mugge A, Brandes RP, Heublein B, et al. Endothelial dysfunction in heart transplanted patients with graft vasculopathy. Eur Heart J 1995; 16(suppl): 78.
20. Rickenbacher PR, Pinto FJ, Lewis NP, et al. Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation. Circulation 1995; 92: 3445.
21. Sellke FW, Shafique T, Ely DL, et al. Coronary endothelial injury after cardiopulmonary bypass and ischemic cardioplegia is mediated by oxygen-derived free radicals. Circulation 1993; 88: II395.
22. Young JB. Allograft vasculopathy: Diagnosing the nemesis of heart transplantation. Circulation 1999; 100: 458.
23. Heindl B, Reichle FM, Zahler S, et al. Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postischemic adhesion of polymorphonuclear neutrophils. Anesthesiology 1999; 91: 521.
24. Zahler S, Kupatt C, Seligmann C, et al. Retention of leucocytes in reperfused, isolated hearts does not cause haemodynamically relevant permanent capillary plugging. Pflugers Arch 1997; 433: 713.
25. Zahler S, Kowalski C, Brosig A, et al. The function of neutrophils isolated by a magnetic antibody cell separation technique is not altered in comparison to a density gradient centrifugation method. J Immunol Methods 1997; 200: 173.
26. Chappell D, Jacob M, Rehm M, et al. Heparinase selectively sheds heparan sulphate from the endothelial glycocalyx. Biol Chem 2008; 389: 79.
27. Mobert J, Becker BF, Zahler S, et al. Hemodynamic effects of isoprostanes (8-iso-prostaglandin F2alpha and E2) in isolated guinea pig hearts. J Cardiovasc Pharmacol 1997; 29: 789.
28. Becker BF, Reinholz N, Ozcelik T, et al. Uric acid as radical scavenger and antioxidant in the heart. Pflugers Arch 1989; 415: 127.
29. Vogel J, Sperandio M, Pries AR, et al. Influence of the endothelial glycocalyx on cerebral blood flow in mice. J Cereb Blood Flow Metab 2000; 20: 1571.
30. Moazami N, Pasque MK, Moon MR, et al. Mechanical support for isolated right ventricular failure in patients after cardiotomy. J Heart Lung Transpl 2004; 23: 1371.
31. Luft JH. Fine structures of capillary and endocapillary layer as revealed by ruthenium red. Fed Proc 1966; 25: 1773.
32. Nieuwdorp M, van Haeften TW, Gouverneur MC, et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 2006; 55: 480.
33. Jacob M, Rehm M, Loetsch M, et al. The endothelial glycocalyx prefers albumin for evoking shear stress-induced, nitric oxide-mediated coronary dilatation. J Vasc Res 2007; 44: 435.
34. Baicu SC, Taylor MJ. Acid-base buffering in organ preservation solutions as a function of temperature: New parameters for comparing buffer capacity and efficiency. Cryobiology 2002; 45: 33.
35. van der Plaats A, 't Hart NA, Morariu AM, et al. Effect of University of Wisconsin organ-preservation solution on haemorheology. Transpl Int 2004; 17: 227.
36. Morariu AM, van der Plaats A, Oeveren V, et al. Hyperaggregating effect of hydroxyethyl starch components and University of Wisconsin solution on human red blood cells: A risk of impaired graft perfusion in organ procurement? Transplantation 2003; 76: 37.
37. Southard JH, Belzer FO. The University of Wisconsin organ preservation solution: Components, comparisons, and modifications. Transpl Rev 1993; 7: 176.
38. Saitoh Y, Hashimoto M, Ku K, et al. Heart preservation in HTK solution: Role of coronary vasculature in recovery of cardiac function. Ann Thorac Surg 2000; 69: 107.
39. Reichenspurner H, Russ C, Uberfuhr P, et al. Myocardial preservation using HTK solution for heart transplantation. A multicenter study. Eur J Cardiothorac Surg 1993; 7: 414.
40. Gu K, Kin S, Saitoh Y, et al. HTK solution is more effective than UW solution for cardiac preservation. Transplant Proc 1996; 28: 1906.
41. Kober IM, Obermayr RP, Ehsani N, et al. HTK versusUWsolution for myocardial protection during moderate hypothermia. Eur Surg Res 1997; 29: 264.
42. Pearl JM, Laks H, Drinkwater DC, et al. Loss of endothelium-dependent vasodilatation and nitric oxide release after myocardial protection with University of Wisconsin solution. J Thorac Cardiovasc Surg 1994; 107: 257.
43. Yang Q, Zhang RZ, Yim AP, et al. Histidine-tryptophan-ketoglutarate solution maximally preserves endothelium-derived hyperpolarizing factor-mediated function during heart preservation: Comparison with University of Wisconsin solution. J Heart Lung Transplant 2004; 23: 352.
44. Garlicki M. May preservation solution affect the incidence of graft vasculopathy in transplanted heart? Ann Transplant 2003; 8: 19.
45. Parolari A, Rubini P, Cannata A, et al. Endothelial damage during myocardial preservation and storage. Ann Thorac Surg 2002; 73: 682.
46. Tanoue Y, Morita S, Hisahara M, et al. Arresting donor hearts with extracellular-type cardioplegia prevents vasoconstriction induced by UW solution. Cardiovasc Surg 1998; 6: 622.
47. Miller LW. Long-term complications of cardiac transplantation. Prog Cardiovasc Dis 1991; 33: 229.